Legend Biotech (LEGN)
(Delayed Data from NSDQ)
$48.68 USD
+1.20 (2.53%)
Updated Oct 2, 2024 04:00 PM ET
After-Market: $48.68 0.00 (0.00%) 7:00 PM ET
3-Hold of 5 3
F Value B Growth A Momentum C VGM
Brokerage Reports
0 items in cart
Legend Biotech Corporation Sponsored ADR [LEGN]
Reports for Purchase
Showing records 1 - 20 ( 43 total )
Company: Legend Biotech Corporation Sponsored ADR
Industry: Medical - Biomedical and Genetics
Company: Legend Biotech Corporation Sponsored ADR
Industry: Medical - Biomedical and Genetics
CARVYKTI 2L Launch Off to Strong Start; 2Q24 Financial Results; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: KAPOOR M
Company: Legend Biotech Corporation Sponsored ADR
Industry: Medical - Biomedical and Genetics
2Q24 CARVYKTI Sales Beat Estimates; Return to Q/Q Growth; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: KAPOOR M
Company: Legend Biotech Corporation Sponsored ADR
Industry: Medical - Biomedical and Genetics
Positive Overall Survival Results for Phase 3 CARTITUDE-4 Trial; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: KAPOOR M
Company: Legend Biotech Corporation Sponsored ADR
Industry: Medical - Biomedical and Genetics
Bispecific Competitors Unlikely to Challenge CARVYKTI Franchise; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: KAPOOR M
Company: Legend Biotech Corporation Sponsored ADR
Industry: Medical - Biomedical and Genetics
ASCO Phase 2 Frontline Data Showcase Early CARVYKTI Usage Power; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: KAPOOR M
Company: Legend Biotech Corporation Sponsored ADR
Industry: Medical - Biomedical and Genetics
Near-Term Estimate Changes; Outlook Still Quite Strong; Lowering PT to $73
Provider: H.C. Wainwright & Co., Inc.
Analyst: KAPOOR M
Company: Legend Biotech Corporation Sponsored ADR
Industry: Medical - Biomedical and Genetics
Substantial Growth Expected in 2H24; 1Q24 Results; Modulating PT to $86
Provider: H.C. Wainwright & Co., Inc.
Analyst: KAPOOR M
Company: Legend Biotech Corporation Sponsored ADR
Industry: Medical - Biomedical and Genetics
New Data Show Secondary Malignancies Not Linked to CAR-T; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: Research Department
Company: Legend Biotech Corporation Sponsored ADR
Industry: Medical - Biomedical and Genetics
CARVYKTI Receives EU Approval in 2L+ Multiple Myeloma; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: KAPOOR M
Company: Legend Biotech Corporation Sponsored ADR
Industry: Medical - Biomedical and Genetics
CARVYKTI Poised For Substantial Growth in 2024; Flat Quarter Not Indicative of a Slowdown; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: KAPOOR M
Company: Legend Biotech Corporation Sponsored ADR
Industry: Medical - Biomedical and Genetics
CARVYKTI Approved in 2L MM; Release Specifications Relaxed; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: KAPOOR M
Company: Legend Biotech Corporation Sponsored ADR
Industry: Medical - Biomedical and Genetics
Novartis Supply Deal Expands Capacity as 2L Decision Nears; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: KAPOOR M
Company: Legend Biotech Corporation Sponsored ADR
Industry: Medical - Biomedical and Genetics
Key Takeaways From ODAC 11-0 Vote Favoring CARVYKTI in 2L; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: KAPOOR M
Company: Legend Biotech Corporation Sponsored ADR
Industry: Medical - Biomedical and Genetics
OS Is Clearer than Kaplan-Meier Curves Project; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: KAPOOR M
Company: Legend Biotech Corporation Sponsored ADR
Industry: Medical - Biomedical and Genetics
ODAC Briefing Docs Today; ODAC Friday; 2023 Financials; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: KAPOOR M
Company: Legend Biotech Corporation Sponsored ADR
Industry: Medical - Biomedical and Genetics
CHMP Opinion Further Validates Path to CARVYKTI 2L Approval; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: KAPOOR M
Company: Legend Biotech Corporation Sponsored ADR
Industry: Medical - Biomedical and Genetics
First TIL Approval Validates Cell Therapy Class
Provider: H.C. Wainwright & Co., Inc.
Analyst: KAPOOR M
Company: Legend Biotech Corporation Sponsored ADR
Industry: Medical - Biomedical and Genetics
New York Investor Dinner Event Key Takeaways; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: KAPOOR M
Company: Legend Biotech Corporation Sponsored ADR
Industry: Medical - Biomedical and Genetics
AdCom Opinion Next Month: Positive CARVYKTI Implications; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: KAPOOR M